Recent Analyst Forecasts and Stock Ratings
Lexeo Therapeutics, Inc. Common Stock FAQ's
Lexeo Therapeutics, Inc. Common Stock has been rated by research analysts at Cantor Fitzgerald, H.C. Wainwright, Guggenheim, Chardan Capital, Leerink Partners, Robert W. Baird in the past 90 days.